N@N

Bernstein Liebhard LLP Announces Investigation on Behalf of Shareholders of Genzyme Corporation

^{Published on 2010-08-31 09:45:32 - Market Wire}
 

NEW YORK--([ BUSINESS WIRE ])--Bernstein Liebhard LLP is investigating whether the Board of Directors of Genzyme Corporation (aGenzymea or the aCompanya) (Nasdaq: GENZ) is breaching its fiduciary duty to the Companya™s shareholders by not agreeing to sell Genzyme to Sanofi-Aventis and/or not seeking to maximize value for the Companya™s shareholders.

If you are interested in discussing your rights as a Genzyme shareholder and/or have information relating to the matter, please contact U. Seth Ottensoser at (877) 779-1414 or [ Ottensoser@bernlieb.com ].

Bernstein Liebhard has pursued hundreds of securities, [ consumer ] and shareholder rights cases and recovered almost $3 billion for its clients. It has been named to The National Law Journala™s aPlaintiffsa™ Hot Lista in each of the last seven years.

ATTORNEY ADVERTISING. © 2010 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.